| Date Filed | Type | Description |
| 11/21/2022 |
4
| McHugh Julie (Director) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Disposed/sold 16,095 shares
@ $15.25, valued at
$245.4k
Disposed/sold 7,800 options to buy
@ $13.27, valued at
$103.5k
Disposed/sold 16,854 options to buy
@ $6.11, valued at
$103k
|
|
| 11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/21/2022 |
4
| McDonnell Peter J (Director) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Disposed/sold 7,995 shares
@ $15.25, valued at
$121.9k
Disposed/sold 16,854 options to buy
@ $6.11, valued at
$103k
|
|
| 11/21/2022 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Disposed/sold 280,244 shares
@ $15.25, valued at
$4.3M
Disposed/sold 25,000 options to buy
@ $3.15, valued at
$78.8k
Disposed/sold 65,941 options to buy
@ $8.8, valued at
$580.3k
|
|
| 11/21/2022 |
4
| Lang Peter Frederick (CFO) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Disposed/sold 46,297 shares
@ $15.25, valued at
$706k
Disposed/sold 160,551 options to buy
@ $8.8, valued at
$1.4M
|
|
| 11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/21/2022 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Disposed/sold 11,495 shares
@ $15.25, valued at
$175.3k
Disposed/sold 1,996 shares
@ $15.25, valued at
$30.4k
Disposed/sold 7,800 options to buy
@ $13.27, valued at
$103.5k
Disposed/sold 16,854 options to buy
@ $6.11, valued at
$103k
|
|
| 11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/21/2022 |
4
| Calabrese Jeffrey (Vice President of Finance) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Disposed/sold 18,585 shares
@ $15.25, valued at
$283.4k
Disposed/sold 6,257 options to buy
@ $11.02, valued at
$69k
Disposed/sold 20,774 options to buy
@ $8.36, valued at
$173.7k
|
|
| 11/21/2022 |
4
| KANNAN RAJ (CEO) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Disposed/sold 215,783 shares
@ $15.25, valued at
$3.3M
Disposed/sold 387,169 options to buy
@ $8.11, valued at
$3.1M
Disposed/sold 197,239 options to buy
@ $8.8, valued at
$1.7M
|
|
| 11/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| McHugh Julie (Director) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Granted 6,245 shares
@ $0
Granted 16,854 options to buy
@ $6.11, valued at
$103k
|
|
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| McDonnell Peter J (Director) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Granted 6,245 shares
@ $0
Granted 16,854 options to buy
@ $6.11, valued at
$103k
|
|
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| du Toit Michael (Director) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Granted 6,245 shares
@ $0
Granted 16,854 options to buy
@ $6.11, valued at
$103k
|
|
| 06/13/2022 |
4
| Croarkin Richard (Director) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Granted 6,245 shares
@ $0
Granted 16,854 options to buy
@ $6.11, valued at
$103k
|
|
| 03/22/2022 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Granted 19,015 shares
@ $0
Granted 65,941 options to buy
@ $8.8, valued at
$580.3k
|
|
| 03/22/2022 |
4
| LaRocca John (General Counsel) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Granted 19,015 shares
@ $0
Granted 65,941 options to buy
@ $8.8, valued at
$580.3k
|
|
| 03/22/2022 |
4
| KANNAN RAJ (CEO) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Granted 197,239 options to buy
@ $8.8, valued at
$1.7M
|
|
| 03/22/2022 |
4
| Lang Peter Frederick (CFO) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Granted 46,297 shares
@ $0
Granted 160,551 options to buy
@ $8.8, valued at
$1.4M
|
|
| 03/22/2022 |
3
| Lang Peter Frederick (CFO) has filed a Form 3 on AERIE PHARMACEUTICALS INC |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| LaRocca John (General Counsel) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 1,973 shares
@ $6, valued at
$11.8k
|
|
| 02/09/2022 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 701 shares
@ $7.24, valued at
$5.1k
Paid exercise price by delivering 700 shares
@ $7.33, valued at
$5.1k
|
|
| 02/09/2022 |
4
| LaRocca John (General Counsel) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 768 shares
@ $7.24, valued at
$5.6k
|
|
| 02/09/2022 |
4
| MITRO THOMAS A (President and COO) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 1,310 shares
@ $7.24, valued at
$9.5k
Paid exercise price by delivering 1,111 shares
@ $7.33, valued at
$8.1k
|
|
| 02/08/2022 |
4
| Hollander David (Chief R&D Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 927 shares
@ $7.05, valued at
$6.5k
|
|
| 02/08/2022 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 963 shares
@ $7.05, valued at
$6.8k
Paid exercise price by delivering 876 shares
@ $7.05, valued at
$6.2k
|
|
|